Exhibit 99.1
Contact: | Media: | Investors: | ||
Tony Plohoros | John Elicker | |||
Communications | Investor Relations | |||
212-546-4379 | 212-546-3775 | |||
tony.plohoros@bms.com | john.elicker@bms.com | |||
Jeff Schoenborn | Blaine Davis | |||
Communications | Investor Relations | |||
212-546-2846 | 212-546-4631 | |||
jeffrey.schoenborn@bms.com | blaine.davis@bms.com |
BRISTOL-MYERS SQUIBB CLOSES PREVISOUSLY ANNOUNCED SALE OF ITS
OTN DISTRIBUTION BUSINESS TO ONE EQUITY PARTNERS LLC
(NEW YORK, May 11, 2005) – Bristol-Myers Squibb Company (NYSE: BMY) today announced that it has completed the sale of its Oncology Therapeutics Network (OTN) distribution business to One Equity Partners LLC.
The divestiture of OTN reflects Bristol-Myers Squibb’s strategic focus on developing its pipeline and new product opportunities in disease areas of significant unmet medical need where innovative medicines can help people with serious illnesses.
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.
###